InMode, an Israeli maker of minimally-invasive medical aesthetic systems, raised $70 million by offering 5 million shares at $14, the low end of the range of $14 to $16. InMode plans to list on the Nasdaq under the symbol INMD. Barclays and UBS Investment Bank acted as lead managers on the deal.
